Sophia Randolph, CHIEF MEDICAL OFFICER at ALX ONCOLOGY HOLDINGS INC (ALXO), sold 22,203 shares at $15.82 ($353K) on 2024-05-13, disclosed to the SEC on 2024-05-15.
Scheduled sale ($353k) by CHIEF MEDICAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.82 | 10,203 | $161K | 45.8% |
| 2 | $15.82 | 10,203 | $161K | 45.8% |
| 3 | $16.67 | 1,797 | $30K | 8.5% |
| Total | $15.89 avg | 22,203 | $353K | 100% |
| Filing → |
| ALXO | SELL | 2024-01-03 | $47K | — | Filing → |
| ALXO | SELL | 2023-07-05 | $12K | — | Filing → |
| ALXO | SELL | 2023-01-03 | $18K | — | Filing → |